Global Oncology Based Preclinical CRO Market Insights and Forecast to 2028

Report ID: 1240507 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Blood Cancer
        1.2.3 Solid Tumors
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Oncology Based Preclinical CRO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 In Vitro
        1.3.3 In Vivo
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oncology Based Preclinical CRO Market Perspective (2017-2028)
    2.2 Oncology Based Preclinical CRO Growth Trends by Region
        2.2.1 Oncology Based Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oncology Based Preclinical CRO Historic Market Size by Region (2017-2022)
        2.2.3 Oncology Based Preclinical CRO Forecasted Market Size by Region (2023-2028)
    2.3 Oncology Based Preclinical CRO Market Dynamics
        2.3.1 Oncology Based Preclinical CRO Industry Trends
        2.3.2 Oncology Based Preclinical CRO Market Drivers
        2.3.3 Oncology Based Preclinical CRO Market Challenges
        2.3.4 Oncology Based Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oncology Based Preclinical CRO Players by Revenue
        3.1.1 Global Top Oncology Based Preclinical CRO Players by Revenue (2017-2022)
        3.1.2 Global Oncology Based Preclinical CRO Revenue Market Share by Players (2017-2022)
    3.2 Global Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oncology Based Preclinical CRO Revenue
    3.4 Global Oncology Based Preclinical CRO Market Concentration Ratio
        3.4.1 Global Oncology Based Preclinical CRO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncology Based Preclinical CRO Revenue in 2021
    3.5 Oncology Based Preclinical CRO Key Players Head office and Area Served
    3.6 Key Players Oncology Based Preclinical CRO Product Solution and Service
    3.7 Date of Enter into Oncology Based Preclinical CRO Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology Based Preclinical CRO Breakdown Data by Type
    4.1 Global Oncology Based Preclinical CRO Historic Market Size by Type (2017-2022)
    4.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2023-2028)
5 Oncology Based Preclinical CRO Breakdown Data by Application
    5.1 Global Oncology Based Preclinical CRO Historic Market Size by Application (2017-2022)
    5.2 Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oncology Based Preclinical CRO Market Size (2017-2028)
    6.2 North America Oncology Based Preclinical CRO Market Size by Type
        6.2.1 North America Oncology Based Preclinical CRO Market Size by Type (2017-2022)
        6.2.2 North America Oncology Based Preclinical CRO Market Size by Type (2023-2028)
        6.2.3 North America Oncology Based Preclinical CRO Market Share by Type (2017-2028)
    6.3 North America Oncology Based Preclinical CRO Market Size by Application
        6.3.1 North America Oncology Based Preclinical CRO Market Size by Application (2017-2022)
        6.3.2 North America Oncology Based Preclinical CRO Market Size by Application (2023-2028)
        6.3.3 North America Oncology Based Preclinical CRO Market Share by Application (2017-2028)
    6.4 North America Oncology Based Preclinical CRO Market Size by Country
        6.4.1 North America Oncology Based Preclinical CRO Market Size by Country (2017-2022)
        6.4.2 North America Oncology Based Preclinical CRO Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Oncology Based Preclinical CRO Market Size (2017-2028)
    7.2 Europe Oncology Based Preclinical CRO Market Size by Type
        7.2.1 Europe Oncology Based Preclinical CRO Market Size by Type (2017-2022)
        7.2.2 Europe Oncology Based Preclinical CRO Market Size by Type (2023-2028)
        7.2.3 Europe Oncology Based Preclinical CRO Market Share by Type (2017-2028)
    7.3 Europe Oncology Based Preclinical CRO Market Size by Application
        7.3.1 Europe Oncology Based Preclinical CRO Market Size by Application (2017-2022)
        7.3.2 Europe Oncology Based Preclinical CRO Market Size by Application (2023-2028)
        7.3.3 Europe Oncology Based Preclinical CRO Market Share by Application (2017-2028)
    7.4 Europe Oncology Based Preclinical CRO Market Size by Country
        7.4.1 Europe Oncology Based Preclinical CRO Market Size by Country (2017-2022)
        7.4.2 Europe Oncology Based Preclinical CRO Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oncology Based Preclinical CRO Market Size (2017-2028)
    8.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Type
        8.2.1 Asia-Pacific Oncology Based Preclinical CRO Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Oncology Based Preclinical CRO Market Share by Type (2017-2028)
    8.3 Asia-Pacific Oncology Based Preclinical CRO Market Size by Application
        8.3.1 Asia-Pacific Oncology Based Preclinical CRO Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Oncology Based Preclinical CRO Market Share by Application (2017-2028)
    8.4 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region
        8.4.1 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Oncology Based Preclinical CRO Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Oncology Based Preclinical CRO Market Size (2017-2028)
    9.2 Latin America Oncology Based Preclinical CRO Market Size by Type
        9.2.1 Latin America Oncology Based Preclinical CRO Market Size by Type (2017-2022)
        9.2.2 Latin America Oncology Based Preclinical CRO Market Size by Type (2023-2028)
        9.2.3 Latin America Oncology Based Preclinical CRO Market Share by Type (2017-2028)
    9.3 Latin America Oncology Based Preclinical CRO Market Size by Application
        9.3.1 Latin America Oncology Based Preclinical CRO Market Size by Application (2017-2022)
        9.3.2 Latin America Oncology Based Preclinical CRO Market Size by Application (2023-2028)
        9.3.3 Latin America Oncology Based Preclinical CRO Market Share by Application (2017-2028)
    9.4 Latin America Oncology Based Preclinical CRO Market Size by Country
        9.4.1 Latin America Oncology Based Preclinical CRO Market Size by Country (2017-2022)
        9.4.2 Latin America Oncology Based Preclinical CRO Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oncology Based Preclinical CRO Market Size (2017-2028)
    10.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type
        10.2.1 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Oncology Based Preclinical CRO Market Share by Type (2017-2028)
    10.3 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application
        10.3.1 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Oncology Based Preclinical CRO Market Share by Application (2017-2028)
    10.4 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country
        10.4.1 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Oncology Based Preclinical CRO Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Crown Bioscience
        11.1.1 Crown Bioscience Company Details
        11.1.2 Crown Bioscience Business Overview
        11.1.3 Crown Bioscience Oncology Based Preclinical CRO Introduction
        11.1.4 Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.1.5 Crown Bioscience Recent Developments
    11.2 Charles River
        11.2.1 Charles River Company Details
        11.2.2 Charles River Business Overview
        11.2.3 Charles River Oncology Based Preclinical CRO Introduction
        11.2.4 Charles River Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.2.5 Charles River Recent Developments
    11.3 ICON
        11.3.1 ICON Company Details
        11.3.2 ICON Business Overview
        11.3.3 ICON Oncology Based Preclinical CRO Introduction
        11.3.4 ICON Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.3.5 ICON Recent Developments
    11.4 Eurofins Scientific
        11.4.1 Eurofins Scientific Company Details
        11.4.2 Eurofins Scientific Business Overview
        11.4.3 Eurofins Scientific Oncology Based Preclinical CRO Introduction
        11.4.4 Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.4.5 Eurofins Scientific Recent Developments
    11.5 Taconic Biosciences
        11.5.1 Taconic Biosciences Company Details
        11.5.2 Taconic Biosciences Business Overview
        11.5.3 Taconic Biosciences Oncology Based Preclinical CRO Introduction
        11.5.4 Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.5.5 Taconic Biosciences Recent Developments
    11.6 Covance
        11.6.1 Covance Company Details
        11.6.2 Covance Business Overview
        11.6.3 Covance Oncology Based Preclinical CRO Introduction
        11.6.4 Covance Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.6.5 Covance Recent Developments
    11.7 EVOTEC
        11.7.1 EVOTEC Company Details
        11.7.2 EVOTEC Business Overview
        11.7.3 EVOTEC Oncology Based Preclinical CRO Introduction
        11.7.4 EVOTEC Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.7.5 EVOTEC Recent Developments
    11.8 The Jackson Laboratory
        11.8.1 The Jackson Laboratory Company Details
        11.8.2 The Jackson Laboratory Business Overview
        11.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Introduction
        11.8.4 The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.8.5 The Jackson Laboratory Recent Developments
    11.9 MI Bioresearch
        11.9.1 MI Bioresearch Company Details
        11.9.2 MI Bioresearch Business Overview
        11.9.3 MI Bioresearch Oncology Based Preclinical CRO Introduction
        11.9.4 MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.9.5 MI Bioresearch Recent Developments
    11.10 Champion Oncology
        11.10.1 Champion Oncology Company Details
        11.10.2 Champion Oncology Business Overview
        11.10.3 Champion Oncology Oncology Based Preclinical CRO Introduction
        11.10.4 Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.10.5 Champion Oncology Recent Developments
    11.11 Wuxi AppTec.
        11.11.1 Wuxi AppTec. Company Details
        11.11.2 Wuxi AppTec. Business Overview
        11.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Introduction
        11.11.4 Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.11.5 Wuxi AppTec. Recent Developments
    11.12 Xentech
        11.12.1 Xentech Company Details
        11.12.2 Xentech Business Overview
        11.12.3 Xentech Oncology Based Preclinical CRO Introduction
        11.12.4 Xentech Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.12.5 Xentech Recent Developments
    11.13 Living Tumor Laboratory
        11.13.1 Living Tumor Laboratory Company Details
        11.13.2 Living Tumor Laboratory Business Overview
        11.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Introduction
        11.13.4 Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022)
        11.13.5 Living Tumor Laboratory Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Oncology Based Preclinical CRO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Blood Cancer
    Table 3. Key Players of Solid Tumors
    Table 4. Key Players of Others
    Table 5. Global Oncology Based Preclinical CRO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Oncology Based Preclinical CRO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Oncology Based Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Oncology Based Preclinical CRO Market Share by Region (2017-2022)
    Table 9. Global Oncology Based Preclinical CRO Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Oncology Based Preclinical CRO Market Share by Region (2023-2028)
    Table 11. Oncology Based Preclinical CRO Market Trends
    Table 12. Oncology Based Preclinical CRO Market Drivers
    Table 13. Oncology Based Preclinical CRO Market Challenges
    Table 14. Oncology Based Preclinical CRO Market Restraints
    Table 15. Global Oncology Based Preclinical CRO Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Oncology Based Preclinical CRO Revenue Share by Players (2017-2022)
    Table 17. Global Top Oncology Based Preclinical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2021)
    Table 18. Ranking of Global Top Oncology Based Preclinical CRO Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Oncology Based Preclinical CRO Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Oncology Based Preclinical CRO Product Solution and Service
    Table 22. Date of Enter into Oncology Based Preclinical CRO Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2017-2022)
    Table 26. Global Oncology Based Preclinical CRO Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Oncology Based Preclinical CRO Revenue Market Share by Type (2023-2028)
    Table 28. Global Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Oncology Based Preclinical CRO Revenue Share by Application (2017-2022)
    Table 30. Global Oncology Based Preclinical CRO Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Oncology Based Preclinical CRO Revenue Share by Application (2023-2028)
    Table 32. North America Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Oncology Based Preclinical CRO Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Oncology Based Preclinical CRO Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Oncology Based Preclinical CRO Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Oncology Based Preclinical CRO Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Oncology Based Preclinical CRO Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Oncology Based Preclinical CRO Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Oncology Based Preclinical CRO Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Oncology Based Preclinical CRO Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Crown Bioscience Company Details
    Table 63. Crown Bioscience Business Overview
    Table 64. Crown Bioscience Oncology Based Preclinical CRO Product
    Table 65. Crown Bioscience Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 66. Crown Bioscience Recent Developments
    Table 67. Charles River Company Details
    Table 68. Charles River Business Overview
    Table 69. Charles River Oncology Based Preclinical CRO Product
    Table 70. Charles River Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 71. Charles River Recent Developments
    Table 72. ICON Company Details
    Table 73. ICON Business Overview
    Table 74. ICON Oncology Based Preclinical CRO Product
    Table 75. ICON Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 76. ICON Recent Developments
    Table 77. Eurofins Scientific Company Details
    Table 78. Eurofins Scientific Business Overview
    Table 79. Eurofins Scientific Oncology Based Preclinical CRO Product
    Table 80. Eurofins Scientific Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 81. Eurofins Scientific Recent Developments
    Table 82. Taconic Biosciences Company Details
    Table 83. Taconic Biosciences Business Overview
    Table 84. Taconic Biosciences Oncology Based Preclinical CRO Product
    Table 85. Taconic Biosciences Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 86. Taconic Biosciences Recent Developments
    Table 87. Covance Company Details
    Table 88. Covance Business Overview
    Table 89. Covance Oncology Based Preclinical CRO Product
    Table 90. Covance Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 91. Covance Recent Developments
    Table 92. EVOTEC Company Details
    Table 93. EVOTEC Business Overview
    Table 94. EVOTEC Oncology Based Preclinical CRO Product
    Table 95. EVOTEC Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 96. EVOTEC Recent Developments
    Table 97. The Jackson Laboratory Company Details
    Table 98. The Jackson Laboratory Business Overview
    Table 99. The Jackson Laboratory Oncology Based Preclinical CRO Product
    Table 100. The Jackson Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 101. The Jackson Laboratory Recent Developments
    Table 102. MI Bioresearch Company Details
    Table 103. MI Bioresearch Business Overview
    Table 104. MI Bioresearch Oncology Based Preclinical CRO Product
    Table 105. MI Bioresearch Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 106. MI Bioresearch Recent Developments
    Table 107. Champion Oncology Company Details
    Table 108. Champion Oncology Business Overview
    Table 109. Champion Oncology Oncology Based Preclinical CRO Product
    Table 110. Champion Oncology Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 111. Champion Oncology Recent Developments
    Table 112. Wuxi AppTec. Company Details
    Table 113. Wuxi AppTec. Business Overview
    Table 114. Wuxi AppTec. Oncology Based Preclinical CRO Product
    Table 115. Wuxi AppTec. Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 116. Wuxi AppTec. Recent Developments
    Table 117. Xentech Company Details
    Table 118. Xentech Business Overview
    Table 119. Xentech Oncology Based Preclinical CRO Product
    Table 120. Xentech Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 121. Xentech Recent Developments
    Table 122. Living Tumor Laboratory Company Details
    Table 123. Living Tumor Laboratory Business Overview
    Table 124. Living Tumor Laboratory Oncology Based Preclinical CRO Product
    Table 125. Living Tumor Laboratory Revenue in Oncology Based Preclinical CRO Business (2017-2022) & (US$ Million)
    Table 126. Living Tumor Laboratory Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncology Based Preclinical CRO Market Share by Type: 2021 VS 2028
    Figure 2. Blood Cancer Features
    Figure 3. Solid Tumors Features
    Figure 4. Others Features
    Figure 5. Global Oncology Based Preclinical CRO Market Share by Application: 2021 VS 2028
    Figure 6. In Vitro Case Studies
    Figure 7. In Vivo Case Studies
    Figure 8. Oncology Based Preclinical CRO Report Years Considered
    Figure 9. Global Oncology Based Preclinical CRO Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Oncology Based Preclinical CRO Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Oncology Based Preclinical CRO Market Share by Region: 2021 VS 2028
    Figure 12. Global Oncology Based Preclinical CRO Market Share by Players in 2021
    Figure 13. Global Top Oncology Based Preclinical CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Oncology Based Preclinical CRO Revenue in 2021
    Figure 15. North America Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
    Figure 17. North America Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
    Figure 18. North America Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
    Figure 19. United States Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
    Figure 25. Germany Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Oncology Based Preclinical CRO Market Size Share by Region (2017-2028)
    Figure 35. China Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
    Figure 45. Mexico Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Oncology Based Preclinical CRO Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Oncology Based Preclinical CRO Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Oncology Based Preclinical CRO Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Oncology Based Preclinical CRO Market Size Share by Country (2017-2028)
    Figure 51. Turkey Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Oncology Based Preclinical CRO Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Crown Bioscience Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 55. Charles River Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 56. ICON Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 57. Eurofins Scientific Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 58. Taconic Biosciences Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 59. Covance Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 60. EVOTEC Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 61. The Jackson Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 62. MI Bioresearch Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 63. Champion Oncology Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 64. Wuxi AppTec. Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 65. Xentech Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 66. Living Tumor Laboratory Revenue Growth Rate in Oncology Based Preclinical CRO Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Frequently Asked Questions
Oncology Based Preclinical CRO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Based Preclinical CRO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Based Preclinical CRO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Linoleic Acid

Linoleic Acid market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More